NCT04080609View on ClinicalTrials.gov

DDI Study Between Dorzagliatin and Rifampicin

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

April 17, 2018

Study Completion Date

April 17, 2018

Conditions
Drug Interaction
Interventions
DRUG

Dorzagliatin

GKA currently under clinical development

Trial Locations (1)

201203

Central Hospital of Xuhui District, Shanghai

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT04080609 - DDI Study Between Dorzagliatin and Rifampicin | Biotech Hunter | Biotech Hunter